JAMDA
August 9, 2018
Showing 41 - 50 of 2346 results
JAMDA
September 24, 2014
Use of Antipsychotic Drugs Among Residents With Dementia in European Long-Term Care Facilities: Results From the SHELTER Study
Behavioral and psychological symptoms of dementia (BPSD) are common reasons for use of antipsychotic drugs among older individuals with dementia. These drugs are not approved for such use and both the Food and Drug Administration and European Medicines Agency have issued warnings to limit such use.
JAMDA
February 25, 2016
Curtailing Antipsychotic Use in LTC Medicine: Reducing Off-Label Antipsychotic Medication Use Among Maine Skilled Nursing Centers with the CALM Intervention
JAMDA
September 24, 2016
Perceptions of Gown and Glove Use to Prevent Methicillin-resistant Transmission in Nursing HomesStaphylococcus aureusPerceptions of Gown and Glove Use to Prevent Methicillin-resistant Transmission in Nursing Homes
To explore current use and perceptions of glove and gown use in nursing homes.
JAMDA
August 14, 2014
Associated Factors With Antipsychotic Use in Long-Term Institutional Care in Eight European Countries: Results From the RightTimePlaceCare Study
To determine factors associated with the antipsychotic (AP) prescription for people with dementia (PwD) recently admitted to institutional long-term care facilities (LTCFs) and to ascertain differences in the use of this medication in 8 European countries.
JAMDA
January 28, 2021
Cognition-Enhancing, Antipsychotic, and Opioid Medication Use Among Assisted Living and Residential Care Residents in Oregon
Explore community- and resident-level characteristics associated with polypharmacy and use of cognition-enhancing, antipsychotic, and opioid medications among a statewide representative sample of assisted living and residential care (AL/RC) residents.
JAMDA
June 8, 2024
Prevalence and Correlates of Antipsychotic Medication Use in Oregon Assisted Living
Investigate how assisted living and residential care (AL/RC) and memory care (MC) contexts are associated with the 90-day prevalence of antipsychotic medication use (APU), considered a quality measure in long-term care.
JAMDA
June 22, 2018
Antipsychotic Deprescription for Older Adults in Long-term Care: The HALT Study
Despite limited efficacy and significant safety concerns, antipsychotic medications are frequently used to treat behavioral and psychological symptoms of dementia (BPSD) in long-term residential care. This study evaluates the sustained reduction of antipsychotic use for BPSD through a deprescribing interve...
JAMDA
December 24, 2020
Geographic Variation in Anticoagulant Use and Resident, Nursing Home, and County Characteristics Associated With Treatment Among US Nursing Home Residents
To quantify geographic variation in anticoagulant use and explore what resident, nursing home, and county characteristics were associated with anticoagulant use in a clinically complex population.
Policy Snapshot
July 21, 2023